Featured News
Traverse Biosciences Executes Exclusive, Worldwide License Agreement
Mar 16 2015
NEW YORK, NY
Traverse Biosciences, founded by Joseph Scaduto - one of the Center for Biotechnology's first BioEntrepreneurs-in-Residence, annou
Learn MoreMillennial Materials and Devices Presenting at NY Business Plan Competition FinalsApr 8 2015
Gaurav Lalwani, PhD, Biomedical Engineering department at Stony brook University and Center for Biotechnology Fundamentals Program
Learn MoreNew Mathematical Model May Improve Drug Discovery - Study Co-Authored by CFB's Dr. Eleanor AllenApr 22 2015
A new mathematical model that uses drug-target kinetics to predict how drugs work in vivo may provide a foundation to improve drug
Learn More-
Center for Biotechnology Announces Redesignation as New York State Center for Advanced TechnologyJuly 17, 2025
The Redesignation brings $10 million in funding to drive innovation, company formation, and economic growth. The Center for Biotechnology (CFB) has announced its re-designated as a Center for Advanced Technology (CAT) by Empire State Development‘s Division of Science, Technology and …
Learn More -
Applications Open: New York State Commercialization Competition July 7, 2025
FuzeHub is accepting applications for its ninth New York State Commercialization Competition. Startups can compete for awards up to $150K to advance the commercialization of their innovative products or technologies.
Learn More -
NYSTAR-supported AI Advancements Make Strides in Fight Against CancerJune 30, 2025
Envisagenics, supported by the Center for Biotechnology at Stony Brook University, is a pioneering biotech company that has been applying AI to drug target discovery for over a decade. In drug development, targets are molecular structures (often proteins) where drugs …
Learn More
Upcoming Events
No Events